ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank27
3Y CAGR-4.9%
5Y CAGR+16.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-4.9%/yr
vs +0.9%/yr prior
5Y CAGR
+16.3%/yr
Recent deceleration
Acceleration
-5.7pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.13B | -9.6% |
| 2025 | $5.67B | -16.9% |
| 2024 | $6.83B | +14.7% |
| 2023 | $5.95B | +82.0% |
| 2022 | $3.27B | +35.6% |
| 2021 | $2.41B | +7.7% |
| 2020 | $2.24B | -61.1% |
| 2019 | $5.75B | +54.1% |
| 2018 | $3.73B | -48.0% |
| 2017 | $7.18B | - |